Stanislav Glezer - Sep 1, 2022 Form 4 Insider Report for Inogen Inc (INGN)

Role
EVP, Chief Technology Officer
Signature
/s/ Leslyn Cicekli, as Attorney-in-Fact
Stock symbol
INGN
Transactions as of
Sep 1, 2022
Transactions value $
-$44,380
Form type
4
Date filed
9/6/2022, 09:27 PM
Previous filing
May 12, 2022
Next filing
Dec 5, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction INGN Common Stock Options Exercise $0 +3.08K $0.00 3.08K Sep 1, 2022 Direct
transaction INGN Common Stock Sale -$44.4K -1.58K -51.25% $28.16 1.5K Sep 1, 2022 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction INGN Restricted Stock Unit Options Exercise $0 -3.08K -25% $0.00 9.22K Sep 1, 2022 Common Stock 3.08K Direct F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The reported shares were sold to cover the Reporting Person's tax withholding liability in connection with a portion of a time-based restricted stock award that vested on September 1, 2022.
F2 Each restricted stock unit represents a contingent right to receive one share of Inogen common stock.
F3 Subject to the reporting person's continued service, 25% of the restricted stock units shall vest on September 1, 2022, and 1/16th of the restricted stock units shall vest every three months thereafter on the 1st day of the month.